Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Neurocrine Bioscienc (NBIX)

59.42 -1.45 (-2.38%)

10/18/2017  4:00pm

Open:

61.53

Pre. Close:

60.87

High:

61.66

Low:

59.35

Volume:

652,848

Market Cap:

5.24B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

62.3 - 63.34

63.34 - 64.58

Low:

56.66 - 57.63

57.63 - 58.79

Close:

57.84 - 59.2

59.2 - 60.82

Technical analysis  (as of: 2017-10-18 4:43:35 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 70.99     One year: 74.48

Support:

Support1: 55.95    Support2: 46.55

Resistance:

Resistance1: 60.78    Resistance2: 63.77

Pivot:

61.62

Moving Averages:

MA(5): 61.18     MA(20): 60.86

MA(100): 52.12     MA(250): 48.19

MACD:

MACD(12,26): 1.15     Signal(12,26,9): 1.58

%K %D:

%K(14,3): 44.25     %D(3): 60.37

RSI:

RSI(14): 47.36

52-Week:

High: 63.77  Low: 37.35  Change(%): 30.1

Average Vol(K):

3-Month: 79952  10-Days 36393

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
NBIX has closed below the lower band by 5.1%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 41.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to NBIX's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 16 Aug 2017 15:33:45 GMT
Neurocrine Biosciences: Ingrezza's Strong Launch, Pipeline To Create Value

Fri, 04 Aug 2017 14:48:45 GMT
Neurocrine Biosciences Off To A Good Start With Ingrezza

Mon, 14 Aug 2017 13:07:30 GMT
This Could Be A Game-Changing Month For Neurocrine Biosciences

Thu, 05 Oct 2017 11:03:45 GMT
Neurocrine Announces FDA Approval of 80 mg INGREZZA® (valbenazine) Capsules ...

Mon, 16 Oct 2017 17:15:00 GMT
How Is Neurocrine Biosciences Positioned Now?

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

Shares Float (M)

82.25

% Held by Insiders

1.20

% Held by Institutions

110.54

Shares Short (K)

9390

Shares Short Prior Month (K)

8920

Stock Financials

EPS

-2.520

EPS Est. Current Year

-2.450

EPS Est. Next Year

-1.700

EPS Est. Next Quarter

-0.410

Forward EPS

-1.730

Book Value (p.s.)

3.910

PEG Ratio

1.87

Profit Margin

Operating Margin

-3502.56

Return on Assets (ttm)

-23.4

Return on Equity (ttm)

-60.5

Qtrly Rev. Growth

Gross Profit (p.s.)

0.170

Sales Per Share

EBITDA (p.s.)

-2.493

Qtrly Earnings Growth

Operating Cash Flow (M)

-188.23

Levered Free Cash Flow (M)

-112.93

FoxReading.com

Valuation

P/E

-23.58

P/E Growth Ratio

-0.02

P/BV

15.20

P/S

74886176768.00

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

1995-12-29

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.